Godsey & Gibb, Inc
Source: SEC Form 13F · as of Mar 2026Godsey & Gibb, Inc holds 17 biotech & pharma companies tracked by BioSniper, totaling $84.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$84.1M
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 185,572 | $28.3M |
| MRKMerck & Co., Inc. | 229,420 | $27.6M |
| AMGNAMGEN INC | 71,485 | $25.2M |
| LLYELI LILLY & Co | 1,190 | $1.1M |
| PMPhilip Morris International Inc | 3,621 | $599K |
| JNJJOHNSON & JOHNSON | 1,854 | $453K |
| ABBVAbbVie Inc. | 1,775 | $386K |
| ABTABBOTT LABORATORIES | 2,282 | $234K |
| CORCencora Inc. | 529 | $166K |
| BMYBRISTOL MYERS SQUIBB CO | 455 | $28K |
| PFEPFIZER INC | 778 | $22K |
| ELVElevance Health Inc. | 66 | $19K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 32 | $11K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 25 | $7K |
| CRSPCRISPR Therapeutics AG | 108 | $5K |
| VTRSViatris Inc | 232 | $3K |
| OGNOrganon & Co. | 1 | $6 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.